Paul B. Moore, MD
Endocrinology, Diabetes & Metabolism Physician · Austin, TX
Paul B. Moore, MD is an endocrinology, diabetes & metabolism physician with a practice address in Austin, Texas, and NPI 1114986999, issued on Mar 21, 2006. Check the license (Texas E4542, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.
- Name
- Paul B. Moore
- Credential
- MD
- Primary taxonomy
- Endocrinology, Diabetes & Metabolism Physician 207RE0101X
- License number
- E4542 TX
Self-reported in NPPES; status is on the state search - Practice location
- 12221 N Mopac Expy, Austin, TX 78758
- Phone
- (512) 901-4005
- Enumerated
- Mar 21, 2006
- Record last updated
- Jan 28, 2022
- Fax
- (512) 901-3905
- Medicaid ID
- 123751303 TX
- Entity
- Type 1 · individual
8 nearest endocrinology, diabetes & metabolism physician records → All 743 in Texas → Look up another NPI →
Also registered at 12221 N Mopac Expy
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Juine Abraham, RN., NP-CFamily Nurse Practitioner1194095133
- Farrah Alahmady, AAAnesthesiologist Assistant1083198014
- Fernanda AlmeidaRegistered Dietitian1487009775
- Mirjana Antelj-RojasFamily Nurse Practitioner1548712946
- Pamela Ashley, MDEmergency Medicine Physician1780630889
- Antoinette Austin-Glass, MDAnesthesiology Physician1790723138
Verify Paul B. Moore in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersTexas Medical Board
Search for license E4542Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
2.7 times the Medicare Part D claims of the average endocrinology, diabetes & metabolism physician in 2024
7,050 Medicare Part D claims for 721 beneficiaries, against an average of 2,630 among the 8,223 providers of this specialty who prescribed in Part D. Brand-name drugs were 46% of claims.
Most prescribed
- Levothyroxine Sodium850 claims
- Ozempic443 claims
- Metformin Hcl Er359 claims
- Atorvastatin Calcium331 claims
- Lantus Solostar285 claims
- Mounjaro254 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $52.07
3 payments; by number, the most common kind was food and beverage; the largest payer was Dexcom, Inc. The 5,661 providers of this specialty with any payment received $5,742.15 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Paul B. Moore among 743 endocrinology, diabetes & metabolism physician records in Texas
Paul B. Moore, MD is one of 743 endocrinology, diabetes & metabolism physician records with a practice address in Texas. 87% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2006, is newer than 6% of them.
- NPI issued2006 · 6% of these records are older, 61% newer
- In a Medicare fileYes · 87% of these records are
- In the CMS Doctors and Clinicians fileNo · 75% of these records are
- Record last updated2022 · 50% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RE0101X and a Texas practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Endocrinology, Diabetes & Metabolism Physician providers in Texas
There are 743 endocrinology, diabetes & metabolism physician records in Texas.
All 743 in Texas → Every provider in Austin → Endocrinology, Diabetes & Metabolism Physician nationwide →
The 8 endocrinology, diabetes & metabolism physician records with the nearest ZIP codes
- Kate Geary, DOAustin, TX 787581518122423
- Jonathan Heckart, DOAustin, TX 787581073004156
- Preethi Ilangovan, M.D.Austin, TX 787581992048185
- Kavita Juneja, MDAustin, TX 787581780709873
- Jesslyn Lu, M.D.Austin, TX 787581225363153
- Devika Madhavan, MDAustin, TX 787581972923274
- Michele McDermott, MDAustin, TX 787581760451199
- Simona Scumpia, M.D.Austin, TX 787581689778946
Common questions
What is Paul B. Moore, MD's NPI number?
Paul B. Moore, MD's National Provider Identifier (NPI) is 1114986999, issued on Mar 21, 2006. An NPI identifies a provider in billing; it is not a license.
Where is Paul B. Moore, MD located?
The NPPES record lists a practice address at 12221 N Mopac Expy, Austin, TX, 78758. Phone: (512) 901-4005. Providers update this record themselves, so call before visiting.
How can I verify Paul B. Moore, MD's license?
NPPES lists Texas license number E4542, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Paul B. Moore, MD prescribe under Medicare Part D?
In 2024, Paul B. Moore, MD had 7,050 Medicare Part D claims for 721 beneficiaries; the average among endocrinology, diabetes & metabolism physician prescribers was 2,630. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.